Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.06 USD | +1.90% | -0.24% | +18.48% |
05-02 | Wedbush Raises SpringWorks Therapeutics' Price Target to $75 From $70, Keeps Outperform Rating | MT |
05-02 | SpringWorks Therapeutics Shares Fall After Wider-Than-Expected Q1 Loss | MT |